58 related articles for article (PubMed ID: 9207175)
1. Association of coatomer proteins with the beta-receptor for platelet-derived growth factor.
Hansen K; Rönnstrand L; Rorsman C; Hellman U; Heldin CH
Biochem Biophys Res Commun; 1997 Jun; 235(3):455-60. PubMed ID: 9207175
[TBL] [Abstract][Full Text] [Related]
2. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
4. Differential interaction of CrkII adaptor protein with platelet-derived growth factor alpha- and beta-receptors is determined by its internal tyrosine phosphorylation.
Matsumoto T; Yokote K; Take A; Takemoto M; Asaumi S; Hashimoto Y; Matsuda M; Saito Y; Mori S
Biochem Biophys Res Commun; 2000 Apr; 270(1):28-33. PubMed ID: 10733900
[TBL] [Abstract][Full Text] [Related]
5. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
6. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding.
Ekman S; Thuresson ER; Heldin CH; Rönnstrand L
Oncogene; 1999 Apr; 18(15):2481-8. PubMed ID: 10229199
[TBL] [Abstract][Full Text] [Related]
7. Selection and characterization of small random transmembrane proteins that bind and activate the platelet-derived growth factor beta receptor.
Freeman-Cook LL; Dixon AM; Frank JB; Xia Y; Ely L; Gerstein M; Engelman DM; DiMaio D
J Mol Biol; 2004 May; 338(5):907-20. PubMed ID: 15111056
[TBL] [Abstract][Full Text] [Related]
8. Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.
Hansen K; Johnell M; Siegbahn A; Rorsman C; Engström U; Wernstedt C; Heldin CH; Rönnstrand L
EMBO J; 1996 Oct; 15(19):5299-313. PubMed ID: 8895575
[TBL] [Abstract][Full Text] [Related]
9. Low M(r) phosphotyrosine protein phosphatase interacts with the PDGF receptor directly via its catalytic site.
Chiarugi P; Cirri P; Raugei G; Manao G; Taddei L; Ramponi G
Biochem Biophys Res Commun; 1996 Feb; 219(1):21-5. PubMed ID: 8619809
[TBL] [Abstract][Full Text] [Related]
10. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
12. Receptor association and tyrosine phosphorylation of S6 kinases.
Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
[TBL] [Abstract][Full Text] [Related]
13. Mapping of tyrosine kinase autophosphorylation sites with synthetic peptide substrates.
Turck CW; Edenson SP
Pept Res; 1994; 7(3):140-5. PubMed ID: 8081070
[TBL] [Abstract][Full Text] [Related]
14. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling.
Yamamoto M; Toya Y; Jensen RA; Ishikawa Y
Exp Cell Res; 1999 Mar; 247(2):380-8. PubMed ID: 10066366
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
16. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.
Jousset C; Carron C; Boureux A; Quang CT; Oury C; Dusanter-Fourt I; Charon M; Levin J; Bernard O; Ghysdael J
EMBO J; 1997 Jan; 16(1):69-82. PubMed ID: 9009269
[TBL] [Abstract][Full Text] [Related]
17. The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.
Wollberg P; Lennartsson J; Gottfridsson E; Yoshimura A; Rönnstrand L
Biochem J; 2003 Mar; 370(Pt 3):1033-8. PubMed ID: 12444928
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells.
Nilson LA; Gottlieb RL; Polack GW; DiMaio D
J Virol; 1995 Sep; 69(9):5869-74. PubMed ID: 7543592
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation.
Irusta PM; DiMaio D
EMBO J; 1998 Dec; 17(23):6912-23. PubMed ID: 9843497
[TBL] [Abstract][Full Text] [Related]
20. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
Petti LM; Reddy V; Smith SO; DiMaio D
J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
